CN1[C@H]2CC[C@@H]1CC(OC(c1ccccc1)c1ccccc1)C2.CS(=O)(=O)O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?